Beth Israel Lahey Health Behavioral Services/Solstice Day School

Beth Israel Lahey Health Behavioral Services/Solstice Day School is a SAMHSA-registered addiction-treatment facility located at Rowley, MA. The facility's programming is outpatient (Outpatient, Dual Dx), not residential. Patient-level evaluation of this facility should distinguish three considerations: state licensure status, voluntary accreditation (CARF or Joint Commission), and clinical-framework alignment with current ASAM Criteria — each of which is independently verifiable.

Care levels at Beth Israel Lahey Health Behavioral Services/Solstice Day School

Beth Israel Lahey Health Behavioral Services/Solstice Day School is an outpatient-focused program (Outpatient, Dual Dx) — patients live at home or in sober living and attend treatment sessions. This level of care is clinically appropriate for mild-to-moderate substance use disorder, or for patients stepping down from residential. Operational prerequisite for admission: documented clinical assessment establishing medical necessity for the specific level of care Beth Israel Lahey Health Behavioral Services/Solstice Day School provides. The ASAM Criteria 4e framework is the benchmark standard for this assessment and is referenced in most major payer medical-necessity documents.

Insurance and payment

Payment and insurance posture: Payment and insurance specifics for Beth Israel Lahey Health Behavioral Services/Solstice Day School are not fully documented in the SAMHSA registry — a direct admissions conversation is the reliable way to confirm what forms of payment are accepted and at what network-contract level. Pre-admission Verification of Benefits (VOB) documentation should include: specific plan product and network status, deductible status at time of admission, coinsurance rate applicable, prior authorization status and turnaround, and out-of-pocket accumulation. Under MHPAEA 2024 disclosure rules, plan-specific medical-necessity criteria must be available on request.

Specialty programming

The facility's documented specialty programming includes: Clients who have experienced trauma, Children/adolescents with serious emotional disturbance (SED). Clinical verification of specialty programming should encompass credentialed staff profile, programming-hour documentation, and specialty-specific medical-necessity documentation for third-party authorization. The MHPAEA 2024 rule addresses specialty-program network adequacy for patients requiring specific clinical capabilities.

Before you call

Pre-admission due-diligence for Beth Israel Lahey Health Behavioral Services/Solstice Day School: (1) ASAM 4e level-of-care documentation matching clinical assessment; (2) written Verification of Benefits specific to insurance product; (3) MAT policy documentation (particularly buprenorphine and methadone continuation protocols for opioid use disorder patients); (4) accreditation verification via CARF or Joint Commission provider-search tools; (5) state licensing status confirmed via MA behavioral-health regulator inspection records. If the clinical situation involves opioid use disorder, confirm explicitly whether Beth Israel Lahey Health Behavioral Services/Solstice Day School offers medication-assisted treatment — buprenorphine, methadone, or naltrexone. Programs that do not are operating outside the current standard of care.